🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I've posted Dr. Jarzembowski's (Jason Jarzembowski) outstanding ISIMM Web webinar to the website. Linked to here: isimm.org/2025/04/06/wha… Enjoy!

ISIMM (ISIMM Web) is THRILLED to announce a new Trainee Membership category. Registration is FREE for trainees. This thread will provide step-by-step instructions for Regular (aka Founder) and Trainee Membership. Step 1: Go here😊 isimm.org/registration/ Looks like this:

Correlation of MammaPrint to Histopathologic Variables and Comparison to Magee Equations in Adjuvant and Neoadjuvant Cohorts of Estrogen-Receptor Positive HER2-Negative Breast Carcinoma journals.lww.com/appliedimmunoh…

Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia ✨hTERT shows stronger nuclear staining in B-CLL cells vs. normal; linked to poor B-CLL prognosis #IHCpath #hemepath Katrina Collins, MD || Pathologist Andrew Bellizzi 🇺🇦 🔗 journals.lww.com/appliedimmunoh…

Differential Expression Patterns of Bcl-2, D2-40, β-Catenin, and E-Cadherin in Thymomas: Correlation With Clinical Stages and Subtypes journals.lww.com/appliedimmunoh…

🧬 Immunohistochemistry in Thymomas ▪️ Bcl-2 and D2-40 positivity varies across thymoma subtypes ▪️ E-cadherin is reduced in invasive tumors ▪️ β-catenin shows subtype-specific expression patterns 📊 66 resected cases analyzed byrk_bsr #pathtwitter #pathology #thymoma

Evaluation of Diagnostic Accuracy of Immunohistochemical Markers of SATB2 and Villin in Differential Diagnosis of Ovarian and Gastrointestinal Mucinous Carcinoma journals.lww.com/appliedimmunoh…

The Value of Routine Reflex In Situ Hybridization Testing in Low-grade Tubule-forming Invasive Breast Cancers With Equivocal HER2 Immunohistochemistry - A Reappraisal of the ASCO/CAP Guidelines journals.lww.com/appliedimmunoh…

CD140b (PDGFRB) Expression in Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma and its Cutaneous Neoplastic Mimics journals.lww.com/appliedimmunoh…

Just published! Check out this latest article by Reza Taha, MD Fouad Boulos 👉🏻 HER2 amplification is rare (1.7%) in low-grade, tubule-forming breast cancers with 2+ HER2 IHC; findings suggest ISH may be unnecessary in this subset #breastpath #IHCpath WashU Medicine Pathology & Immunology

Expression of Hippo Pathway Molecules in Distal Bile Duct Cancer journals.lww.com/appliedimmunoh…

I'm delighted to share that the recording of CristinaMagiGalluzzi's ISIMM Web webinar has been added to our website: isimm.org/diagnostic-imm… I'm also sharing several #wallhangers from the webinar (1/2)

🚨 In distal bile duct cancer: 🔹 LATS1/2 expressed in 29.9% ➡️ linked to better prognosis 🔹 YAP (52.2%) & TEAD4 (19.4%) ➡️ tied to advanced stage & worse survival 🔍 Combined LATS1/2⁺ + YAP/TEAD4ˡᵒʷ ➡️ independent favorable prognostic marker #HippoPathway #LATS1 #YAP #TEAD4

Immune Profiling of Incidental NSCLC Patients: Comparison Between Tumor Sections and TMA Cores journals.lww.com/appliedimmunoh…

Just published! Check out this latest article! 🔵 PD-L1 expression showed high concordance between cores and full slides. 🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates. Fábio Tavora, MD, PhD #IHCpath #lungcancer

The Expression and Clinical Features of 8 Immunohistochemistry Markers in Adrenal Cortical Adenomas and Pheochromocytomas journals.lww.com/appliedimmunoh…

Deciphering the Molecular Landscape of Urothelial Carcinoma: Immunohistochemistry-based Subtyping Using 4 Easily Available Antibodies for Cost-effective Stratification journals.lww.com/appliedimmunoh…

Just published! Check out this latest article by Shreeya Indulkar Dr. B. Vishal Rao 🔬 Molecular subtyping of bladder cancer is vital—but often out of reach 🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs ⚠️ Dual-negative had poorest survival (25%), luminal best (80%)

We’re one day away from David Dabbs’ ISIMM Web webinar highlighting the HER2 CASI study—our final webinar of the academic year. Register here: us02web.zoom.us/webinar/regist…